Advertisement
Loading...

XOMA Royalty Corp.

XOMANASDAQ
Healthcare
Biotechnology
$41.65
$-0.17(-0.41%)
U.S. Market opens in 62h 39m

XOMA Royalty Corp. Fundamental Analysis

XOMA Royalty Corp. (XOMA) shows strong financial fundamentals with a PE ratio of 15.79, profit margin of 86.97%, and ROE of 30.21%. The company generates $0.0B in annual revenue with strong year-over-year growth of 83.06%.

Key Strengths

ROE30.21%
Cash Position19.17%
PEG Ratio-0.11
Current Ratio3.59

Areas of Concern

No major concerns flagged.
We analyze XOMA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 74.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
74.8/100

We analyze XOMA's fundamental strength across five key dimensions:

Efficiency Score

Excellent

XOMA demonstrates superior asset utilization.

ROA > 10%
11.59%

Valuation Score

Excellent

XOMA trades at attractive valuation levels.

PE < 25
15.79
PEG Ratio < 2
-0.11

Growth Score

Moderate

XOMA shows steady but slowing expansion.

Revenue Growth > 5%
83.06%
EPS Growth > 10%
1.93%

Financial Health Score

Moderate

XOMA shows balanced financial health with some risks.

Debt/Equity < 1
1.10
Current Ratio > 1
3.59

Profitability Score

Excellent

XOMA achieves industry-leading margins.

ROE > 15%
30.21%
Net Margin ≥ 15%
86.97%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is XOMA Expensive or Cheap?

P/E Ratio

XOMA trades at 15.79 times earnings. This indicates a fair valuation.

15.79

PEG Ratio

When adjusting for growth, XOMA's PEG of -0.11 indicates potential undervaluation.

-0.11

Price to Book

The market values XOMA Royalty Corp. at 4.41 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.41

EV/EBITDA

Enterprise value stands at 11.81 times EBITDA. This signals the market has high growth expectations.

11.81

How Well Does XOMA Make Money?

Net Profit Margin

For every $100 in sales, XOMA Royalty Corp. keeps $86.97 as profit after all expenses.

86.97%

Operating Margin

Core operations generate 13.73 in profit for every $100 in revenue, before interest and taxes.

13.73%

ROE

Management delivers $30.21 in profit for every $100 of shareholder equity.

30.21%

ROA

XOMA Royalty Corp. generates $11.59 in profit for every $100 in assets, demonstrating efficient asset deployment.

11.59%

Following the Money - Real Cash Generation

Operating Cash Flow

XOMA Royalty Corp. produces operating cash flow of $6.99M, showing steady but balanced cash generation.

$6.99M

Free Cash Flow

XOMA Royalty Corp. generates strong free cash flow of $6.99M, providing ample flexibility for dividends, buybacks, or growth.

$6.99M

FCF Per Share

Each share generates $0.56 in free cash annually.

$0.56

FCF Yield

XOMA converts 1.27% of its market value into free cash.

1.27%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

15.79

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.41

vs 25 benchmark

P/S Ratio

Price to sales ratio

14.48

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.10

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.59

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.30

vs 25 benchmark

ROA

Return on assets percentage

0.12

vs 25 benchmark

ROCE

Return on capital employed

0.02

vs 25 benchmark

How XOMA Stacks Against Its Sector Peers

MetricXOMA ValueSector AveragePerformance
P/E Ratio15.7928.95 Better (Cheaper)
ROE30.21%747.00% Weak
Net Margin86.97%-49219.00% (disorted) Strong
Debt/Equity1.100.39 Weak (High Leverage)
Current Ratio3.593.98 Strong Liquidity
ROA11.59%-19945.00% (disorted) Strong

XOMA outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews XOMA Royalty Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

5.34%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

41.56%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-83.11%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ